Last reviewed · How we verify
NCT05447962
Community-engaged Hypertension Prevention Program in Black Men
NA trial testing Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP) in Hypertension in 430 participants. Completed in 30 September 2025.
18 March 2025
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 430 |
| Start date | 1 October 2022 |
| Primary completion | 18 March 2025 |
| Estimated completion | 30 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP)
- Barbershop-Based Facilitation (BF)
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
NYU Langone Health — full company profile →
Who can join
Adults 18 to 85, male only, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The CLIP program will train Community Health Workers (CHWs) to screen and identify Black men with elevated blood pressure (BP) or stage 1 hypertension (HTN), initiate lifestyle counseling; and link them to primary care and social services.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Barbershop-Facilitated Community-to-Clinic Linkage Implementation Program: Rationale and Protocol for a Novel Program to Prevent Hypertension Among Black Men.
Ravenell J, Green T, Arabadjian M, Schoenthaler A, et al · · 2023 · cited 5× · PMID 37061797 · DOI 10.1093/ajh/hpac133 -
Community Engagement for Effective Recruitment of Black Men at Risk for Hypertension: Baseline Data From the Community-to-Clinic Program (CLIP) Randomized Controlled Trial.
Arabadjian M, Green T, Foti K, Dubal M, et al · · 2025 · cited 1× · PMID 40482027 · DOI 10.1093/ajh/hpaf099 -
Social Determinants of Health and Health Care Utilization among Hispanic and Non-Hispanic Black Men at Risk for Hypertension.
Arabadjian M, Green T, Foti K, Poudel B, et al · · 2025 · PMID 40949624 · DOI 10.18865/ethndis-2024-30
Verify or expand the search:
- PubMed search for NCT05447962
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05447962 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 27 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05447962.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing